NO20040175L - Acylsemikarbazider som cyklinavhengige kineaseinhibitorer anvendelige som anti-kreft- og anti-proliferative midler - Google Patents

Acylsemikarbazider som cyklinavhengige kineaseinhibitorer anvendelige som anti-kreft- og anti-proliferative midler

Info

Publication number
NO20040175L
NO20040175L NO20040175A NO20040175A NO20040175L NO 20040175 L NO20040175 L NO 20040175L NO 20040175 A NO20040175 A NO 20040175A NO 20040175 A NO20040175 A NO 20040175A NO 20040175 L NO20040175 L NO 20040175L
Authority
NO
Norway
Prior art keywords
acylsemicarbazides
cyclin
cancer
kinase inhibitors
dependent kinase
Prior art date
Application number
NO20040175A
Other languages
English (en)
Norwegian (no)
Inventor
David John Carini
Eddy W Yue
Susan V Dimeo
David Nugiel
Anup Vidwans
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Publication of NO20040175L publication Critical patent/NO20040175L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20040175A 2001-07-16 2004-01-15 Acylsemikarbazider som cyklinavhengige kineaseinhibitorer anvendelige som anti-kreft- og anti-proliferative midler NO20040175L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/906,963 US6593356B2 (en) 1999-10-20 2001-07-16 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
PCT/US2002/022663 WO2003007883A2 (fr) 2001-07-16 2002-07-16 Acylsemicarbazides inhibiteurs de kinase dependant de la cycline utiles en tant qu'agents anticancereux et antiproliferatifs

Publications (1)

Publication Number Publication Date
NO20040175L true NO20040175L (no) 2004-03-12

Family

ID=25423309

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040175A NO20040175L (no) 2001-07-16 2004-01-15 Acylsemikarbazider som cyklinavhengige kineaseinhibitorer anvendelige som anti-kreft- og anti-proliferative midler

Country Status (15)

Country Link
US (1) US6593356B2 (fr)
EP (1) EP1417177A4 (fr)
JP (1) JP2004536853A (fr)
KR (1) KR20040015368A (fr)
CN (1) CN1553900A (fr)
BR (1) BR0211203A (fr)
CA (1) CA2453594A1 (fr)
HU (1) HUP0401588A3 (fr)
IL (1) IL159863A0 (fr)
MX (1) MXPA04000531A (fr)
NO (1) NO20040175L (fr)
PL (1) PL366912A1 (fr)
RU (1) RU2004104329A (fr)
WO (1) WO2003007883A2 (fr)
ZA (1) ZA200400332B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048844A1 (en) * 1999-10-20 2004-03-11 Bristol-Myers Squibb Pharma Company Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
JP3821090B2 (ja) * 2002-10-22 2006-09-13 トヨタ自動車株式会社 内燃機関の始動制御装置
US7456169B2 (en) 2003-02-27 2008-11-25 Abbott Laboratories Inc. Heterocyclic kinase inhibitors
US7320986B2 (en) 2003-03-07 2008-01-22 Abbott Labortories Fused tri and tetra-cyclic pyrazole kinase inhibitors
EP1740579B1 (fr) 2004-03-24 2015-08-19 AbbVie Inc. Inhibiteurs de kinases a base de tyrazoles tricycliques
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
CN105686807B (zh) 2009-08-31 2019-11-15 雅培糖尿病护理公司 医疗设备
EP2552532A1 (fr) 2010-03-24 2013-02-06 Abbott Diabetes Care, Inc. Appareils d'insertion de dispositifs médicaux et procédés d'insertion et d'utilisation de dispositifs médicaux
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
JP6895963B2 (ja) 2015-11-18 2021-06-30 ジェンザイム・コーポレーション 多発性嚢胞腎のバイオマーカーおよびその使用
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407103B2 (en) * 1998-04-21 2002-06-18 Bristol-Myers Squibb Pharma Company Indeno [1,2-c] pyrazol-4-ones and their uses
CN1297442A (zh) * 1998-04-21 2001-05-30 杜邦药品公司 用作抗癌剂和抗增殖剂的5-氨基茚并[1,2-c]吡唑-4-酮类化合物
US6291504B1 (en) * 1999-10-20 2001-09-18 Dupont Pharmaceuticals Company Acylsemicarbazides and their uses
JP2004524277A (ja) * 2000-10-20 2004-08-12 ブリストル−マイヤーズ スクイブ ファーマ カンパニー アシルセミカルバジド及びサイクリン依存性キナーゼ(cdk)阻害剤としてのその使用
US6706718B2 (en) * 2000-12-01 2004-03-16 Bristol-Myers Squibb Company 3-(2,4-dimethylthiazol-5-yl)indeno[1,2-c]pyrazol-4-one derivatives and their uses

Also Published As

Publication number Publication date
WO2003007883A2 (fr) 2003-01-30
HUP0401588A3 (en) 2005-06-28
KR20040015368A (ko) 2004-02-18
PL366912A1 (en) 2005-02-07
US6593356B2 (en) 2003-07-15
CA2453594A1 (fr) 2003-01-30
ZA200400332B (en) 2005-06-29
JP2004536853A (ja) 2004-12-09
IL159863A0 (en) 2004-06-20
EP1417177A2 (fr) 2004-05-12
US20030073686A1 (en) 2003-04-17
EP1417177A4 (fr) 2005-10-19
RU2004104329A (ru) 2005-07-10
HUP0401588A2 (hu) 2005-01-28
MXPA04000531A (es) 2004-05-04
BR0211203A (pt) 2004-09-28
WO2003007883A3 (fr) 2003-05-22
CN1553900A (zh) 2004-12-08

Similar Documents

Publication Publication Date Title
NO20035366L (no) Benzoylsulfonamider og sulfonylbenzamidiner for anvendelse som antitumormidler
NO20033573D0 (no) Vandig viskoelastisk fluid
DE60234125D1 (de) E inhibitoren
PT1370553E (pt) Inibidores de rhoquinase
NO20041887L (no) Benzomidazoler anvendelige som proteinkinase-inhibitorer
DE60205596D1 (de) Schmierölzusammensetzung
NO20034439L (no) Benzamidinderivater
ATE319451T1 (de) Tetrahydrochinolin-derivate
DK3808743T3 (da) HIV-hæmmende pyrimidin-derivater
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
DE60227475D1 (de) Halbleiterbauelement
NO20040175L (no) Acylsemikarbazider som cyklinavhengige kineaseinhibitorer anvendelige som anti-kreft- og anti-proliferative midler
DE50207739D1 (de) Kombinationswerkzeug
DE50200673D1 (de) Ölversorgungseinrichtung
ATE291365T1 (de) Bett-schreibtisch-kombinationsmöbel
NO20014597D0 (no) Fremgangsmåte
ITTO20020789A1 (it) Formulazione solida
DE60223675D1 (de) Homogenisiervorrichtung
DE60225790D1 (de) Halbleiterbauelement
ITMI20020551A1 (it) Dispositivo di avanzamento
DE60202381D1 (de) Paroxetin-n-formyl-derivate
DE50110467D1 (de) Staffelei
DK1453783T3 (da) Substituerede arylcycloalkaner og deres anvendelse som anticancermidler
SE0103064L (sv) Flygplansanpassat utlösningsbart arrangemang
SE0100694D0 (sv) DHFR inhibitors